GSK
1,779.50 GBpChange from previous close: −0.86%Absolute change: −15.50 GBp
At a glance
- Revenue growth
- +4.11%
- 2025 vs 2024
- Net income growth
- +121.98%
- 2025 vs 2024
- Net margin
- 17.5%
- 2024: 8.2%
Financial data
Amounts in millions of GBP; per-share values in GBP; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | 7,741 | 6,554 | 6,768 | 7,403 | 7,952 |
| Depreciation and amortization | 2,094 | 2,340 | 2,294 | 2,147 | 2,122 |
| Capital expenditure | -1,348 | -1,399 | -1,314 | -1,143 | -950 |
| Investing cash flow | -4,233 | -1,229 | -1,595 | -8,772 | -1,777 |
| Financing cash flow | -3,685 | -4,726 | -5,641 | 823 | -7,589 |
| Dividends paid | -2,564 | -2,444 | -2,247 | -3,467 | -3,999 |
| Share repurchases | -1,377 | 0.0 | 0.0 | — | — |
| Debt issued | 3,194 | 1,341 | 223 | 2,046 | 301 |
| Debt repaid | -1,929 | -2,733 | -2,790 | -6,870 | -2,485 |
| Effect of exchange rates | -19.0 | -54.0 | -99.0 | 152 | -29.0 |
| Net change in cash | -196 | 545 | -567 | -394 | -1,443 |
| Free cash flow | 6,393 | 5,155 | 5,454 | 6,260 | 7,002 |
| Levered free cash flow | 3,284 | 4,954 | 3,837 | 4,266 | 4,847 |